Does Astragalus Immune Function Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Astragalus Immune Function Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - However, despite the increasing number of studies, current evidence on YPFS remains fragmented and lacks systematic integration. [Gao Shiyu (2026); evidence level 3] - Further research by Huand Zhaosuggests that YPFS may influence biological processes, including tumor-associated angiogenesis and cell proliferation, by modulating multiple signaling pathways such as AGE-RAGE, IL-17, TNF, and MAPK. [Gao Shiyu (2026); evidence level 3] - Compared with individual herbs, YPFS demonstrates superior efficacy in modulating Th1/Th2 and Th17/Treg balance, improving tumor-associated immunosuppressive microenvironments (eg., PD-1/PD-L1 and STAT3 signaling axes), and enhancing anti-infective capacity. [Gao Shiyu (2026); evidence level 3] - 1 2 3 4 5 6–8 http://mpns.kew.org/ http://mpns.kew.org/ http://mpns.kew.org/ Dan xi Xin Fa Yupingfeng San (YPFS) is a classical traditional Chinese herbal formula (TCM prescription),composed of Astragalus mongholicus Bunge (Huang Qi) (January 22, 2026), Atractylodes macrocephala Koidz. [Gao Shiyu (2026); evidence level 3] - 5 6 7 8 9 Aging is accompanied by a progressive decline in cellular and organ function, leading to an increased incidence of chronic diseases and neurodegenerative disorders. [Kanubaddi Kiran Reddy (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.